BLOISE, RAFFAELLA
 Distribuzione geografica
Continente #
NA - Nord America 779
EU - Europa 649
AS - Asia 405
AF - Africa 4
OC - Oceania 1
Totale 1.838
Nazione #
US - Stati Uniti d'America 775
CN - Cina 378
IE - Irlanda 201
IT - Italia 98
FI - Finlandia 79
UA - Ucraina 76
DE - Germania 61
FR - Francia 48
SE - Svezia 44
GB - Regno Unito 26
SG - Singapore 21
BE - Belgio 4
CA - Canada 4
NL - Olanda 3
BD - Bangladesh 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
IN - India 2
MU - Mauritius 2
RU - Federazione Russa 2
TN - Tunisia 2
AU - Australia 1
GR - Grecia 1
HU - Ungheria 1
IR - Iran 1
JP - Giappone 1
PT - Portogallo 1
Totale 1.838
Città #
Chandler 212
Dublin 201
Jacksonville 111
Nanjing 103
Ashburn 66
Beijing 57
Boardman 47
Nanchang 38
Princeton 38
Lawrence 35
Hebei 31
Shanghai 29
Shenyang 29
Medford 28
Wilmington 28
Changsha 24
Helsinki 23
Jiaxing 22
Hangzhou 16
Singapore 14
Seattle 11
Woodbridge 11
San Genesio Ed Uniti 10
Chicago 9
Milan 8
New York 7
Munich 6
Tianjin 6
Verona 6
Monza 5
Alghero 4
Ann Arbor 4
Brussels 4
Kunming 4
Norwalk 4
Rome 4
Toronto 4
Washington 4
Dallas 3
Dearborn 3
Dresden 3
Fairfield 3
Falls Church 3
Andover 2
Bergamo 2
Bex 2
Bologna 2
Brno 2
Des Moines 2
Los Angeles 2
Naples 2
Orta di Atella 2
Pune 2
Sassari 2
Taizhou 2
Zhengzhou 2
Assemini 1
Bari 1
Cagliari 1
Cento 1
Cherasco 1
Città Di Castello 1
Como 1
Dalmine 1
Forest City 1
Gatchina 1
Genoa 1
Gostar 1
Guiyang 1
Lanzhou 1
Las Vegas 1
Lisbon 1
Ningbo 1
Palermo 1
Pescia 1
Piombino 1
Piscataway 1
Pittsburgh 1
Ripi 1
Rockville 1
Rutigliano 1
San Francisco 1
San Jose 1
Santa Clara 1
Saronno 1
Sestu 1
Shijiazhuang 1
St Petersburg 1
Tappahannock 1
Tokyo 1
Treviglio 1
Turin 1
Vicenza 1
Viterbo 1
Yantai 1
Yinchuan 1
Totale 1.344
Nome #
Tachicardia Ventricolare Polimorfa Catecolaminergica 132
Gene-specific therapy for inherited arrhythmogenic diseases 76
Images in cardiovascular medicine. Endocardial implantation of a cardioverter-defibrillator in a 13-month-old child affected by long-QT syndrome and syndactyly. 75
Clinical and Molecular Characterization of Patients with Catecholominergic Polymorphic Ventricular Tachycardia. 65
Clinical presentation and outcome of Brugada syndrome diagnosed with the new 2013 criteria 63
Clinical profile and genetic basis of Brugada syndrome in the Chinese population. 62
Timothy Syndrome 62
Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome 62
Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome 62
La sindrome di Brugada: epidemiologia, stratificazione del rischio e management clinico. 61
A Molecular Link between the Sudden Infant Death Syndrome and the Long-QT Syndrome. 60
Basi genetiche della morte cardiaca improvvisa 59
L-TYPE CALCIUM CHANNEL DISEASE 59
CaMKII inhibition rectifies arrhythmic phenotype in a patient-specific model of catecholaminergic polymorphic ventricular tachycardia. 59
Postmortem molecular analysis in victims of sudden unexplained death 59
Catecholaminergic polymorphic ventricular tachycardia: successful emergency treatment with intravenous propranolol. 58
Clinical utility gene card for: Catecholaminergic polymorphic ventricular tachycardia (CPVT). 57
Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3 57
Low penetrance mutations and compound heterozygosity in LQTS: phenotypic consequences and implications for the clinical presentation of the disease 53
Romano-Ward and other congenital long QT syndromes 50
La tachicardia ventricolare polimorfa catecolaminergica 48
Association of Hydroxychloroquine with QTc Interval in Patients with COVID-19 47
Test diagnostici in cardiologia 46
Gating Properties of SCN5A Mutations and the Response to Mexiletine in Long-QT Syndrome Type 3 Patients 46
Efficacy and Limitations of Quinidine in Patients with Brugada Syndrome 46
Programmed Electrical Stimulation in Brugada Syndrome: How reproducible are the results? 44
Mutations in the Cardiac Ryanodine Receptor Gene (hRyR2) Underlie Catecholaminergic Polymorphic Ventricular Tachycardia 43
Unexpected Risk Profile of a Large Pediatric Population With Brugada Syndrome 42
Novel insights in the natural history of Short QT Syndrome 35
Identification of a SCN5A founder mutation causing sudden death, Brugada syndrome, and conduction blocks in Southern Italy 33
Unusual retrospective prenatal findings in a male newborn with Timothy syndrome type 1 31
Natural History of Brugada Syndrome: Insights for risk stratification and management 31
Sudden Cardiac Death and Genetic Ion Channelopathies: Long QT, Brugada, Short QT, Catecholaminergic Polymorphic Ventricular Tachycardia, and Idiopathic Ventricular Fibrillation 30
Outcomes of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia Treated With β-Blockers 28
Polymorphisms in the NOS1AP gene modulate QT interval duration and risk of arrhythmias in the long QT syndrome 26
Totale 1.867
Categoria #
all - tutte 7.771
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.771


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020116 0 0 0 0 1 15 0 18 2 39 38 3
2020/2021193 17 21 6 17 2 24 6 25 16 26 22 11
2021/2022158 3 1 5 0 2 4 5 14 8 10 29 77
2022/2023576 58 54 7 59 45 70 0 32 237 1 10 3
2023/2024204 27 28 7 26 16 34 19 20 3 0 8 16
2024/2025104 14 43 14 21 12 0 0 0 0 0 0 0
Totale 1.867